Home » Patent Law Updates » New Judicial Opinions

Patent Law Summaries

Page 32 of 34 of Patent Law Summaries » New Judicial Opinions« First  <  30 31 32 33 34 >

Boston Scientific Scimed, Inc. v. Cordis Corporation

03-283-SLR, 03-1138-SLR, 2007 WL 989192,
D.Del., 04/04/2007

Holding: A court should employ a two-step analysis in determining whether infringement exists or not. First, the court must construe the asserted claims to ascertain their meaning and scope. Construction of the claims is a question of law. The trier of fact must then compare the properly construed claims with the defendant’s infringing product. This second step involves a question of fact. Literal infringement occurs where each limitation of at least one claim of the patent is found exactly in the alleged infringer's product. A defendant’s product that does not literally infringe a patent may still be found guilty of infringement under the doctrine of equivalents if each limitation of the claim is seen in the defendant’s product either literally or equivalently. More...

Zipwall, LLC v. Fastcap. LLC

05-11852-JLT, 2007 WL 1040679,
D.Mass., 04/09/2007

Holding: In construing a patent claim, the court relies on intrinsic evidence, including the claims, specification, and patent file history if presented in evidence, extrinsic evidence, including expert testimony, dictionary definitions, learned treatises, and principles of interpretation. Patent claims are generally given their ordinary and customary meaning, which is the meaning known by a person of ordinary skill in the invention's art. The patent specification is the single best guide to the meaning of a disputed term; however, a court must be careful not to read a limitation from the specification into the claims. More...

Central Admixture Pharmacy Services, Inc. v. Advanced Cardiac Solutions, P.C.

2006-1307, 2007 WL 96793,
Fed.Cir.(Ala.), 04/03/2007

Holding: A patentee who has made “a mistake of a clerical or typographical nature, or of minor character” may apply to the Patent and Trademark Office (PTO) for a certificate of correction, if the correction does not involve such changes in the patent as would constitute new matter or would require re-examination. However, such certificate may be invalidated for “impermissible broadening” upon proof of two elements: (1) the corrected claims are broader than the original claims; and (2) the presence of the clerical or typographical error, or how to correct that error, is not clearly evident to one of skill in the art. More...

Intamin, Ltd. v. Magnetar Technologies, Corp.

05-1546, 05-1579, 2007 WL 1138489,
Fed.Cir.(Cal.), 04/18/2007

Holding: In directing the remand of the case for patent infringement involving magnetic braking system for amusement park rides, the Court of Appeals found that factual matters needed to be threshed out by the district court regarding the issue of whether or not the defendant’s brake system could have been manufactured in such a way that the conducting rail was attached to the track. More...

Ricoh Company, Ltd. v. Asutek Computer, Inc.

06-C-0462-C, 2007 WL 981712,
W.D.Wis., 04/03/2007

Holding: The district court granted defendants’ (foreign competitors’) motion to dismiss a patent infringement suit, stating that it could not exercise personal jurisdiction over the defendants both under the specific and general personal provisions of the Wisconsin long-arm statute. More...

Patent Law Commentaries

Following are Patent Law Commentaries elaborating on the significance of the most important of the Patent Law Summaries.

Page 1 of 2 of Patent Law Commentaries  1 2 >

Quanta Computer v. LG Electronics: Reviving Exhaustion, Applying It to Method Patents

Quanta Computer v. LG Electronics
Posted: 08/15/2008

Commentary: In the case Quanta Computer v. LG Electronics, ___ U.S. ____, 128 S.Ct. 2109 (2008), the United States Supreme Court clarifies and expands upon its holding in United States v. Univis Lens Co. In Univis, the court held that a patent is exhausted upon the sale of unfinished components that substantially embody the patent and which have no use except to practice the patent. In Quanta, the court clarified that the same analysis applies to process or method patents, not just product patents: When a component substantially embodies the process and cannot be used for any purpose other than to practice the patent, the process patent is exhausted upon sale of that component. The decision makes it more difficult for patentees to extract royalties from multiple parties for the same device. However, it revitalizes the integrity of the exhaustion doctrine and provides more certainty for downstream purchasers. More...

Related summary: Supreme Court Reverses Federal Circuit’s Ruling, Finds in Favor of Quanta in LG’s Computer Technology Patent Suit

Acumed II Addresses the Issue of Claim Preclusion and When a Patent Claim Could Have Been Brought

Acumed, LLC v. Stryker Corp., et al.
Posted: 05/20/2008

Commentary: In the recent case of Acumed, LLC v. Stryker Corp.,et al., (No. 2007-1115) (Fed. Cir., May 13, 2008) (“Acumed II”), the Federal Circuit addressed the meaning and application of language barring re-litigation of claims that “could have been brought” in a prior patent infringement case. More...

Related summary: Federal Circuit Reverses District Court’s Ruling in Acumed v. Stryker, Remands Case

Agrizap and Ortho-McNeil: Two Sides of Post-KSR Obviousness

Ortho-McNeil Pharmaceutical, Inc. v. Mylan Laboratories, Inc., et al.
Posted: 05/16/2008

Commentary: In KSR v. Teleflex, 550 U.S. ____, 127 S. Ct. 1727 (2007), the U.S. Supreme Court broadened the applicable test in determining whether an invention is “obvious.” As predicted by patent law pundits, the KSR decision was followed by a number of cases in which infringers defended their actions – and won – by having the patent in question declared invalid for obviousness under this new standard. The Court of Appeals for the Federal Circuit (the CAFC) recently heard and decided two separate cases that addressed the issue of obviousness post-KSR. These cases shed further light on the new standard for determining obviousness. While the results are quite different, the lessons for practitioners are, ultimately, the same. More...

Related summary: Federal Circuit Affirms Validity of Ortho-McNeil’s Patent On Epilepsy Drug Topomax

Judkins v. HT Window Fashion: Can’t Stop a Patent Holder from Contacting Your Clients About Possible Infringement

Judkins v. HT Window Fashion Corp.
Posted: 05/13/2008

Commentary: When a patent-holder discovers infringement, it’s not unreasonable for him to want to notify the alleged infringer’s clients of the infringement. Of course the alleged infringer would prefer that this communication with its clients not take place. But, as the Judkins case instructs, it will be nearly impossible for an alleged infringer to stop a patent holder from contacting its clients. More...

Related summary: Patent Owners Allowed to Warn Buyers about Competitor's Infringing Products: Judkins v. HT Window Fashion Corp.

Tafas v. Dudas: USPTO’s Efforts to Limit Patent Applicant Rights Are Void

Tafas v. Dudas, et al.
Posted: 05/12/2008

Commentary: In an effort to attack its notorious backlog, the USPTO enacted a group of rule changes that placed limits on, among other things, the number of claims a patent applicant could include and the number of times an applicant could amend and continue his application. Traditionally, patent applicants could take unlimited bites at the apple in their pursuit of their patent. In Tafas, the court struck down the rule changes as null and void, and exceeding the scope of the USPTO’s authority. While the Office has the power to enact procedural rules regarding the process, it cannot enact substantive rules – these rules are substantive since they dramatically alter existing policy and the rights and obligations of patent applicants. More...

Related summary: USPTO Rules Are Void For Being Contrary to Law, VA District Court Declares


Email Subscribe to Email Updates
RSS Subscribe to RSS Feeds

Search this Site

Advanced Search

Discussion Forums

Patent Law

Enter our NEW discussion forums to interact with other readers about Patent Law.

Companies Mentioned

Patent Law

The following companies are mentioned in Patent Law Updates:

Stryker Corp.

Boston Scientific Corp.

United States Patent and Trademark Office

Smithkline Beecham Corp. (d.b.a. GlaxoSmithKline, plc.)

HT Window Fashion Corp.

Mylan Laboratories, Inc.

Mylan Pharmaceutical, Inc.

Ortho-McNeil Pharmaceutical, Inc.

Samsung Electronics America, Inc.

Acumed, LLC

Audiovox Communications Corp.

Stryker Sales Corp.

McKesson Information Solutions, Inc.

Stryker Orthopaedics

Bridge Medical, Inc.

Howmedica Osteonics Corp.

Smith & Nephew, Inc.

LG Electronics, Inc.

Quanta Computer, Inc.

Motorola, Inc.

Nokia, Inc.

Sanyo North America Corp.

Scimed Life Systems Inc.

Boston Scientific Scimed, Inc.

Sendo America, Inc.

Sprint Corp.

Mayhew Steel Products, Inc.

Lexion Medical, LLC

Medtronic Vascular, Inc.

Siemens Communications, Inc.

Samsung Electronics Co. Ltd.

Matthews Collins Shepherd & McKay, P.A.

U.S. Patent and Trademark Office

Medtronic USA, Inc.

NEC Corporation of America

Samsung Telecommunications America LLC.

Apotex, Inc.

Cooper Technologies Company

Medtronic, Inc.

Sony Ericcson Mobile Communications (USA), Inc.

Nokia Corp.

Apotex Corp.

Thomas & Betts Corp.

Medtronic Vascular Galway, Ltd.

Sony Ericcson Mobile Communications AG

Nokia Inc.

Roche Palo Alto LLC

800 Adept, Inc.

Bancorp Services, LLC

Panasonic Corporation of North America

Additional Resources

Patent Law

Patent Act (pdf, 1.4mb)

Patent Rules (pdf, 3.4mb)

Manual for Patent Examining Procedure (pdf, 56mb)

Need a Lawyer?

The lawyers at Zuber & Taillieu LLP have top credentials, and offer exceptional services in all areas of law found on LawUpdates.com.

Visit Zuber & Taillieu LLP